|
 |
商品名 |
|
|
商品名仅供参考, 药品所用的辅料可能依国家或厂商不同有所不同。
|
|
Abelcet |
丹麦, 加拿大, 匈牙利, 卢森堡, 墨西哥, 奥地利, 巴西, 希腊, 德国, 意大利, 挪威, 比利时, 法国, 澳大利亚, 爱尔兰, 瑞典, 秘鲁, 罗马尼亚, 美国, 芬兰, 英国, 荷兰, 葡萄牙, 西班牙, 阿根廷, 马来西亚 |
|
|
 |
 |
引用文献 : Amphotericin B lipid complex |
|
|
种类 |
出版物 |
| 1510 |
书籍 |
AHFS Formulary service 2000 Bethesda - 3546 p |
| 2247 |
文献 |
Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278. |
| 2262 |
文献 |
Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265. |
| 3254 |
文献 |
Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L.
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration
Am J Health-Syst Pharm 2011 ; 68: 2265-2270. |
| 3332 |
实验室 |
Tigecycline (Tigacyl®) - Summary of Product characteristics
Pfizer 2012 |
| 3644 |
实验室 |
Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010 |
| 3828 |
海报 |
Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015 |
| 3829 |
海报 |
So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015 |
| 4055 |
文献 |
Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 , 75, 1:36-44 |
| 4964 |
实验室 |
GLUCONATE DE CALCIUM 10 % B.BRAUN, solution pour perfusion - Résumé des caractéristiques du produit.
B BRAUN MELSUNGEN AG 2019 |
| 5068 |
实验室 |
ABELCET 5 mg/ml, suspension à diluer pour perfusion - Résumé des caractéristiques du produit.
ACINO FRANCE SAS 2025 |
|
|
